Renub Research (http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-86) has announced the addition of the "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis" report to its offering
Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.
It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.
In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country.
DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations.
Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market.
PPT- Unmanned Ground Vehicle Market by Product Type, Distribution Channel, En...IMARC Group
Unmanned ground vehicles (UGV) are land robots that operate without the presence of onboard human operators. They are equipped with a set of sensors to monitor and observe the terrain, gather crucial information and then report the findings to the operators who remotely control the vehicle through teleoperation.
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
According to the latest report by IMARC Group the global vaccine market size reached a strong growth in 2020.One of the leading trends witnessed in the global vaccines market is the surging cases of the coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives around the world Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).
PPT- Unmanned Ground Vehicle Market by Product Type, Distribution Channel, En...IMARC Group
Unmanned ground vehicles (UGV) are land robots that operate without the presence of onboard human operators. They are equipped with a set of sensors to monitor and observe the terrain, gather crucial information and then report the findings to the operators who remotely control the vehicle through teleoperation.
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...IMARC Group
According to the latest report by IMARC Group the global vaccine market size reached a strong growth in 2020.One of the leading trends witnessed in the global vaccines market is the surging cases of the coronavirus disease (COVID-19), which has, till date, resulted in the loss of around half a million lives around the world Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).
Infant Radiant Warmer Market is expected to reach US$ 2,420.44 million by 2027Nikhilkumar1082
The infant radiant warmer market was valued at US$ 1,632.70 million in 2019 and is projected to reach US$ 2,420.44 million by 2027; it is expected to grow at a CAGR of 5.1% from 2020 to 2027.
Zoonotic diseases is the rare disease that is usually spread from faunas to humans and from humans to faunas. There are various ways of disease being transferred, such as air by direct contact, by contact with an inert object that harbors the disease, oral ingestion, and by insect. The diseases from wiretaps and other faunas can make sick or death in people. Many health agencies globally have track on the disease and death caused by zoonotic disease. The animals always carry some or the other infective pathogens that can be shared or transmitted with/ to people. Zoonotic diseases may be caused by germs which including bacteria, viruses, parasites, and fungi. Zoonoses when infected can lead to many different types of illnesses in humans and faunas which can be mild to severe that human or animal may die. It is always important to notice that the faunas do not always appear ill or sick when carrying a zoonotic disease, many animals do appear healthy, but they still carry infectious germs that can make people sick.
Zoonotic diseases has become very common now a days throughout the globe. Scientist’s assessment about the zoonotic diseases are that more than 8 out of every 12 known infectious diseases in humans are spread from faunas, and 4 out of every 5 new or emerging infectious diseases in people are spread from faunas. Yearly, estimated, thousands of Americans gets sick from diseases spread between faunas and humans. Because of this, the national health agency works 24/7 to protect people from zoonotic diseases.
Download Global breast cancer vaccine market & clinical pipeline outlook ...KuicK Research
“Global Breast Cancer Vaccine Market and Clinical Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the global breast cancer vaccine development market. Currently there is no single breast cancer vaccine commercially available in the market. This report analyzes the ongoing clinical trial of 36 breast cancer vaccines in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the vaccine. Most of the breast cancer vaccines in clinical trials are in preclinical phase followed by Phase-I trials. The advance stage of development of breast cancer vaccine in clinical trials across the globe is in Phase-III.
The conventional cancer treatment methods have proved their importance in last decade. They are widely accepted among patients and physicians (oncologists) because of familiarity and large amount of statistically significant data supporting their efficacy. Despite their benefits, they sometimes fall short in meeting the patient’s personal requirements. For instance, efficacy is a major requirement, but different patients display different response to the same medication, this is attributed to their unique genetic makeup. To meet the individual’s necessities, high efficacy and safety, concept of cancer vaccine was formulated.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
09 CeoMeeting- Session 4- Medicines for MalariaMLSCF
Session 4: Health & Wellness
Title: The Changing Face Of Healthcare:
Where Are The Opportunities?
Special Speaker: Dr Chris Hentschel, Medicines for Malaria Venture
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
A Small Biotech/Pharma Company with Great Potentials...Novavax's Conference P...DrMuni Neurophysiologist
This is a Novavax Inc's recent Power Point Presentation, a Promising company for those interested in Biotech/Pharma ...The power point presentation wholly belongs to the company but it is publicly shared already, you can also find this on the companies website and on other sites like LinkedIN..
-------------------------------------------------------------------------
Novavax, Inc, Nasdaq: NVAX
This small cap company with a market cap around $700M is a clinical stage pharma/biotech company involved in recombinant nano-particles based vaccines to address newly emerging diseases, infectious diseases, respirator virus, influenza, seasonal flu to Ebola and H7N9 like virus and more, simply put this is a promising company to follow and look into the NVAX stocks, it is a bargain to get this stock here before it fly's away!!!.
Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.
A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032.
More Info:- https://www.imarcgroup.com/pediatric-vaccines-market
“Global HIV Infection Drug Market & Pipeline Insight” Report Highlight:
Global HIV Infection Drug Market Overview & Incidence Scenario
FDA & EMA Regulation for Development of HIV Drug
Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country
Global HIV Clinical Pipeline: 315 Drugs in Development Phases
Majority HIV Drug in Preclinical Phase: 144 Drugs
Marketed HIV Drugs: 37
Suspended & Discounted HIV Drug in Clinical Pipeline: 539 Drugs
Patent Analysis: Patent Number & Technology
Infant Radiant Warmer Market is expected to reach US$ 2,420.44 million by 2027Nikhilkumar1082
The infant radiant warmer market was valued at US$ 1,632.70 million in 2019 and is projected to reach US$ 2,420.44 million by 2027; it is expected to grow at a CAGR of 5.1% from 2020 to 2027.
Zoonotic diseases is the rare disease that is usually spread from faunas to humans and from humans to faunas. There are various ways of disease being transferred, such as air by direct contact, by contact with an inert object that harbors the disease, oral ingestion, and by insect. The diseases from wiretaps and other faunas can make sick or death in people. Many health agencies globally have track on the disease and death caused by zoonotic disease. The animals always carry some or the other infective pathogens that can be shared or transmitted with/ to people. Zoonotic diseases may be caused by germs which including bacteria, viruses, parasites, and fungi. Zoonoses when infected can lead to many different types of illnesses in humans and faunas which can be mild to severe that human or animal may die. It is always important to notice that the faunas do not always appear ill or sick when carrying a zoonotic disease, many animals do appear healthy, but they still carry infectious germs that can make people sick.
Zoonotic diseases has become very common now a days throughout the globe. Scientist’s assessment about the zoonotic diseases are that more than 8 out of every 12 known infectious diseases in humans are spread from faunas, and 4 out of every 5 new or emerging infectious diseases in people are spread from faunas. Yearly, estimated, thousands of Americans gets sick from diseases spread between faunas and humans. Because of this, the national health agency works 24/7 to protect people from zoonotic diseases.
Download Global breast cancer vaccine market & clinical pipeline outlook ...KuicK Research
“Global Breast Cancer Vaccine Market and Clinical Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the global breast cancer vaccine development market. Currently there is no single breast cancer vaccine commercially available in the market. This report analyzes the ongoing clinical trial of 36 breast cancer vaccines in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the vaccine. Most of the breast cancer vaccines in clinical trials are in preclinical phase followed by Phase-I trials. The advance stage of development of breast cancer vaccine in clinical trials across the globe is in Phase-III.
The conventional cancer treatment methods have proved their importance in last decade. They are widely accepted among patients and physicians (oncologists) because of familiarity and large amount of statistically significant data supporting their efficacy. Despite their benefits, they sometimes fall short in meeting the patient’s personal requirements. For instance, efficacy is a major requirement, but different patients display different response to the same medication, this is attributed to their unique genetic makeup. To meet the individual’s necessities, high efficacy and safety, concept of cancer vaccine was formulated.
Biological Safety Testing Market Size, Product Analysis and Applications, 201...Signitech
The global biological safety testing market size was valued at USD 2.20 billion in 2016 and is anticipated to exhibit a CAGR of 12.2% during the forecast period.
09 CeoMeeting- Session 4- Medicines for MalariaMLSCF
Session 4: Health & Wellness
Title: The Changing Face Of Healthcare:
Where Are The Opportunities?
Special Speaker: Dr Chris Hentschel, Medicines for Malaria Venture
United States IVD Market (By Application Segments, Products, Region, End User...iGATE RESEARCH
iGATE Research has released a research report on “United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025”
Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=166
Contact US
iGATE Research PVT LTD
Ravi Sinha
Sales Manager
Marketing and Sales Divison
Email: ravi.sinha@igateresearch.com
Contact: +91-858-684-0791, +91-821-092-7469 (INDIA)
Web: www.igateresearch.com
Molecular diagnostics market & forecast (by application, technology, countrie...Renub Research
Renub Research (http://renub.com/report/molecular-diagnostics-market-forecast-by-application-technology-countries-companies-clinical-trials-to-2017-global-analysis-114) has announced the addition of the "Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis" report to its offering
A Small Biotech/Pharma Company with Great Potentials...Novavax's Conference P...DrMuni Neurophysiologist
This is a Novavax Inc's recent Power Point Presentation, a Promising company for those interested in Biotech/Pharma ...The power point presentation wholly belongs to the company but it is publicly shared already, you can also find this on the companies website and on other sites like LinkedIN..
-------------------------------------------------------------------------
Novavax, Inc, Nasdaq: NVAX
This small cap company with a market cap around $700M is a clinical stage pharma/biotech company involved in recombinant nano-particles based vaccines to address newly emerging diseases, infectious diseases, respirator virus, influenza, seasonal flu to Ebola and H7N9 like virus and more, simply put this is a promising company to follow and look into the NVAX stocks, it is a bargain to get this stock here before it fly's away!!!.
Global Vaccines Market 2020 By Technology [Conjugate vaccines, Inactivated and subunit vaccines, Live attenuated vaccines, Recombinant vaccines, Toxoid vaccines and others],By Type [Monovalent vaccines, Multivalent vaccines and others], By Patient Type[Pediatric patients, Adult patients and others], By Disease[Cancer, Dengue, DTP, Hepatitis, Human Papilloma Virus, Influenza, Meningococcal Disease, Pneumococcal disease, Polio, Rotavirus and others]: Global Forecast to 2026 and COVID-19 Impact Outlook
Global Vaccines Market is valued at USD 45.9 Billion in 2019 and expected to reach USD 91.9 Billion by 2026 with the CAGR of 10.44 % over the forecast period.
A recent report from Renub Research, titled "Global Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," offers a thorough analysis of the industry and market share knowledge. The report also includes research on regions, competitors, and the recent expansion of the Global Vaccine Market.
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032.
More Info:- https://www.imarcgroup.com/pediatric-vaccines-market
“Global HIV Infection Drug Market & Pipeline Insight” Report Highlight:
Global HIV Infection Drug Market Overview & Incidence Scenario
FDA & EMA Regulation for Development of HIV Drug
Global HIV Infection Drug Clinical Pipeline by Phase, Company & Country
Global HIV Clinical Pipeline: 315 Drugs in Development Phases
Majority HIV Drug in Preclinical Phase: 144 Drugs
Marketed HIV Drugs: 37
Suspended & Discounted HIV Drug in Clinical Pipeline: 539 Drugs
Patent Analysis: Patent Number & Technology
Monkeypox Vaccine Market by Product Type, Distribution Channel, End User 2024...IMARC Group
The global monkeypox vaccine market size reached US$ 86.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 421.8 Million by 2032, exhibiting a growth rate (CAGR) of 18.85% during 2024-2032.
More Info:- https://www.imarcgroup.com/monkeypox-vaccine-market
Infantile Spasms Therapeutics Market by Product Type, Distribution Channel, E...IMARC Group
The global infantile spasms therapeutics market size reached US$ 3.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.2% during 2023-2028.
More Info:- https://www.imarcgroup.com/infantile-spasms-therapeutics-market
The value of early asset development and commercializationCello Health
Worldwide pharmaceutical R&D spend is increasing each year, and the competition for a share of that investment is becoming fiercer. Companies need to demonstrate the potential value of their asset in commercial as well as scientific and clinical terms.
The slides in this deck define and identify value from a financial, clinical and commercial perspective while also exploring how to derive value for patients.
The Future Landscape of Covid-19 Vaccine MarketMehdiMehdiyev4
We believe that assessing the potential market for COVID-
19 vaccines is necessary in terms of reevaluating the risk/reward ratio of certain vaccine developing companies.
In addition, an overly utopian outlook for a potential COVID-19 vaccine market may lead to
disappointment and negatively affect future vaccine developers. And this concerns us more.
The global neonatal ventilator market size reached US$ 423.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 699.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.58% during 2024-2032.
More Info:- https://www.imarcgroup.com/neonatal-ventilator-market
Cholera Vaccines Market PPT: Demand, Trends and Business Opportunities 2023-28IMARC Group
The global cholera vaccines market size reached US$ 4.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Million by 2028, exhibiting a growth rate (CAGR) of 11.1% during 2023-2028.
More Info:- https://www.imarcgroup.com/cholera-vaccines-market
Vaccine Adjuvants Market by Product Type, Distribution Channel, End User 2024...IMARC Group
The global vaccine adjuvants market size reached US$ 996.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,639.3 Million by 2032, exhibiting a growth rate (CAGR) of 11.1% during 2024-2032.
More Info:- https://www.imarcgroup.com/vaccine-adjuvants-market
Point of care testing market and forecast to 2016 global analysisRenub Research
Renub Research (http://www.renub.com/report/point-of-care-testing-market-and-forecast-to-2016-global-analysis-88) has announced the addition of the "Point of Care Testing Market and Forecast to 2016: Global Analysis" report to its offering
Point of Care Testing Market and Forecast to 2016: Global Analysis - Market Overview
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Blood glucose test controls a lion’s market share of around 70% for the year 2011 and it is expected to continue its dominance till 2016. Rest of all the others point of care tests market share covered in this report are in single digit. Infectious disease testing market is expected to double by 2016 from its market of 2011. As countries are making the healthcare more and more accessible to people, the demand for various point of care testing is keep on rising. The point of care testing market has become an established sector worldwide and will continue to provide vital contribution in in-vitro diagnostics industry.
This 83 page report contains 26 Figures and 12 Tables provides a comprehensive analysis of the emerging point of care tests market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. Renub Research report entitled “Point of Care Testing Market and Forecast to 2016: Global Analysis” report also provides market landscape and market share information in the point of care testing market. The report brings together major merger & acquisition, distribution agreement, licensing deals information in point of care testing market. The report also entails major drivers and challenges of point of care testing market.
10 Point of Care Test Segments Covered in this Report
Blood Glucose Testing, Cardiac Marker Testing, Lipid Panel/Cholesterol Testing, Blood Coagulation Testing, Infectious Disease Testing, Urinalysis Testing, Drug of Abuse Testing, Fecal Occult Blood Testing, Pregnancy & Fertility Testing and Tumor Marker Testing
Cholera Vaccines Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and ...IMARC Group
The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.
More Info:- https://www.imarcgroup.com/cholera-vaccines-market
The global vaccine delivery devices market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
More info:- https://www.imarcgroup.com/vaccine-delivery-devices-market
Therapeutic Vaccines Market Growth, Demand and Challenges of the Key Industry...IMARC Group
The global therapeutic vaccines market size reached US$ 31.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 71.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/therapeutic-vaccines-market
Research Dive has recently added a new report on Human Papillomavirus Vaccine Market Size Share which provides a succinct analysis of the market size, revenue forecast, and the regional landscape of Human Papillomavirus Vaccine Market Size Share
Biodefense Market PPT 2021-26 | Enhancing Huge Growth and Latest Trends by T...IMARC Group
According to the latest report by IMARC Group,the global biodefense market size reached US$ 12.7 Billion by 2020.
Biodefense includes the utilization of several medical and military measures that are taken to safeguard individuals against bioterrorism.
Similar to Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis (20)
Singapore Medical Tourism Analysis and ForecastRenub Research
Renub Research (http://www.renub.com/report/singapore-medical-tourism-analysis-and-forecast-132) has announced the addition of the "Singapore Medical Tourism Analysis and Forecast" report to its offering
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015Renub Research
If online travel and classifieds were the star performers of the last decade, e-retailing seems to be hogging the limelight this time around. India is rapidly emerging as a rewarding market for many e-retailing companies; who are currently present in the market with any one of the three forms (Non-warehouse, Warehouse and Hybrid) models. The broadband and mobile penetration, 3G rollout, cash on delivery, internet banking has led to rise in online transactions by 18.2% for the year 2011 compared to 2010. Indian e-retail market is also expected to be more than INR 10,000 Crore by 2015.
In our analysis we found that Computer peripherals, Camera & Mobile and Life Style segments are expected hold 1st, 2nd and 3rd positions respectively for 2011. Together they account for more than 70% of total market share in 2011. But by the end of 2015 Camera and Mobile is expected to take the top slot pushing computer peripheral to third position. In companies analysis segment Flipkart is the undisputed leader for the year 2011. Flipkart generated 4 times more revenue than its nearest competitor Yebhi in 2011. However according to our research findings scenario is likely to change in 2012 as Myntra is expected to take the second position leaving Yebhi to third position. For the year 2014 Flipkart and Myntra together is expected to hold more than 50% market share.
In any retail business, some products are returned from the point of consumption. Therefore, the challenge is to set up infrastructure and procedures for reverse logistics. The e-tailors need to have an understandable product return policy on the Web. This report provides a clear picture about the e-retailing scenario in India and its various issues like: Types of business model in Indian e-retail, key companies funding and revenue forecast, driving forces for e-retail, challenges in the e-retail.
Renub Research report entitled “India E-Retail (E-Tailing) Market, Companies Revenue Analysis & Forecast to 2015” provides a comprehensive assessment of the fast-evolving, high-growth e-retail space. We recommend this report as must-read insight for e-retailing stakeholders.
The report covers the following points
• E-Retail business model in India
• India e-retail users transacting online growth forecast from (2010 to 2015)
• Studied growth forecasts and India e-retail market sizing from (2009 to 2015)
• Key players revenue analysis, forecast and funding trends of: Flipkart, Letsbuy, Myntra, HomeShop18, Yebhi, Snapdeal and Naptol from (2010 – 2014)
• Market analysis and forecast for segments: Camera & Mobile, Computer Peripherals, Electronic gadgets, Life style, Books amd Home & kitchen Appliances (2009 – 2015)
• Researched the drivers and challenges for the e-retail industry in India.
Contact Us
Andy Hill
Relationship Manager
Sales & Marketing Div
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) +91-120-254-5750 (India)
Web: http://www.renub.com/
http://renub.com/report/india-frozen-food-poultry-fishseafood-red-meat-dessert-snacks-and-vegetable-market-volume-forecast-to-2017-92
Renub Research has announced the addition of the "India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017" report to its offering
Renub Research study titled “India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017” provides a comprehensive assessment of the fast-evolving, high-growth India frozen food Market. This 99 page report with 44 Figures and 26 Tables provides information on frozen food market and market share by value & volume, frozen food products segmentation by value and volume, frozen food products segmentations by packet value and volume; with key companies’ strategies in India frozen food market. This report also identifies the key growth drivers and challenges of the industry. Primary research on consumer preferences of various packet sizes of frozen food products captured in this report.
India Frozen Food covered in this report has been studied from following view points:
• Primary Research - Consumer Survey on Preferences of Packet Sizes of Frozen Foods in Indian Market
• India Frozen Food Market Value (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Value Share (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Volume (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Volume Share (2010 – 2012) and Forecast (2013 – 2017)
• By Value - India Frozen Food Product Market Segmentation (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Analysis by Packet Size (0-300 Gram, 301-500 Gram, 500 Gram-1 Kg, More than 1 Kg) for Year (2010 – 2012) and Forecast (2013 – 2017)
• India Frozen Food Market Segmentation Analysis by Packet Size (0-300 Gram, 301-500 Gram, 500 Gram-1 Kg, More than 1 Kg) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Packet Size Market Value - India Frozen Food Product Segmentation (Meat, Dessert, Fish/Seafood, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Volume - India Frozen Food Product Market Segmentation (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
• By Packet Size Volume - India Frozen Food Product Market Segmentation (Meat, Fish/Seafood, Dessert, Snacks and Vegetable) for Year (2010 – 2012) and Forecast (2013 – 2017)
Contact Us
Andy Hill
Sr. Manager - Publisher Relation
Relationship Manager
Sales & Marketing Div
Renub Research
Email: info@renub.com
Phone: +1-678-302-0700 (USA) +91-120-254-5750, +91-120-4219-822(India)
Web: http://www.renub.com
4 g (lte and wimax) service revenuemarket analysis and its opportunities for ...Renub Research
Renub Research (http://www.renub.com/report/4g-lte-and-wimax-service-revenuemarket-analysis-and-its-opportunities-for-industries-51) has announced the addition of "4G (LTE and WiMAX) Service Revenue/Market Analysis and its Opportunities for Industries" report to its offering
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015Renub Research
Renub Research (http://www.renub.com/report/india-e-retail-e-tailing-market-companies-revenue-analysis-forecast-to-2015-65) has announced the addition of the "India E-Retail (E-Tailing) Market, Companies Revenue Analysis & Forecast to 2015" report to its offering
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...Renub Research
Renub Research (http://www.renub.com/report/personalized-medicine-diagnostics-flow-cytometry-sepsis-immunos-routine-coagulation-psychiatric-disorders-tumor-markers-molecular-blood-typing-and-other-testing-116) has announced the addition of the "Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing)" report to its offering
Cardivascular bioimplant market analysis publisherRenub Research
Renub Research (http://www.renub.com/report/global-cardiac-bio-implant-devices-implantable-cardioverter-defibrillators-implantable-cardiac-pacemakers-heart-valve-coronary-stent-peripheral-stent-ventricular-assist-device-market-forecast-clinical-trials-ma-115) has announced the addition of the "Global Cardiac Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A" report to its offering
South korea medical tourism number of medical tourists & medical tourism mark...Renub Research
Renub Research (http://www.renub.com/report/south-korea-medical-tourism-number-of-medical-tourists-medical-tourism-market-forecast-to-2015-70) has announced the addition of the "South Korea Medical Tourism: Number of Medical Tourists & Medical Tourism Market Forecast to 2015" report to its offering
India probiotic dairy products (yogurt, drink, ice cream) market, volume & fo...Renub Research
India probiotic market, probiotic drink market, probiotic ice cream market, probiotic yogurt market, probiotic drink sales, probiotic ice cream sales, probiotic yogurt sales, Nestle probiotic revenue,Amul probiotic revenue, Mother Dairy probiotic revenue, yakult probiotic revenue
Indian Probiotic Dairy industry is evolving at a steady pace with opportunities for tremendous growth in near future. India being the largest producer of milk and having world’s highest cattle population has a distinct advantage in the Probiotic field. Indian Probiotic industry is expected to be more than double by 2015 from its current size in 2011. Brands that exist now in Indian Probiotic industry are Nestle, Amul, Yakult Danone and Mother Dairy along with other minor players operating in different regions in their own capacities. Although there are quite a number of challenges in front of domestic and foreign companies entering the Indian Probiotic market, but the advantages associated with the industrial growth prospects outnumber the challenges in an easy and elegant way. The strong fundamental factors for the Probiotic industry in India will pave way for the growth of Indian Dairy Industry in the near future.
Indian Probiotic Dairy Market, Market Share and Forecast:
Amul is the leader with nearly 70% market share in 2011 and is likely to be at the top in the coming years as well. In 2011, Amul Probiotic share accounted for more than double than the combined share of its competitors like Mother Dairy, Nestle and Yakult. Nestle and Mother Dairy is holding second and third position in the Indian Probiotic Market.
Probiotic Dairy Products (Yougurt, Ice Cream, Drink) and Forecast:
Probiotic Yogurt is the leading category which accounts for more than 50% share in 2011 followed by Probiotic Ice Cream and Probiotic drink.
Probiotic Dairy Products Sales Volume and Forecast:
It is expected that Probiotic yogurt sales will cross 100,000 Thousand packets by 2015. Amul is the leader in Probiotic yogurt sales in India and is likely to remain as a leader in the years to come. Probiotic drink sales volume is likely to reach a little less than 100,000 Thousand bottles by the year 2015. In probiotic drink sales volume, Yakult is way ahead than Mother Dairy. Being a lonely player in the probiotic ice cream market in India Amul is gaining advantage.
Although there are formidable challenges to be encountered, the prospects of the market expanding in a steadfast way look bright. As Probiotics are not previewed under any health related law in India and with Indian Council of Medical Research (ICMR) still framing the guidelines for Probiotic sales (ICMR status report on Probiotics, 2009), Probiotics face no hindrance from government health officials on its sales.
Renub Research (http://www.renub.com/report/india-cold-chain-storage-number-market-capacity-forecast-to-2017-91) has announced the addition of the "India Cold Chain Storage Number, Market & Capacity Forecast to 2017" report to its offering
The cold chain industry also considered the sunrise Industry in India because of its robust future outlook. As with high growth prospects for the food processing sector along with attractive government incentives including 51 percent FDI clearance in multi brand retail makes cold chain business a goldmine for foreign investors as well.
India Cold Storage Market Analysis:
• In the year 2012, India cold storage market was XXXX with a combined capacity of XXXX Thousand Metric Tons
• The surface cold storage accounts for XXXX% of the total cold storage market compared to XXXX% of refrigerated transportation in 2012
• In India cold storage market for potato holds the maximum share of XXXX% in 2012.
• The market share of multipurpose cold storage will be XXXX% share by 2017. It is projected that meat and fish will be at 3rd position in the India cold storage market with XXXX% share by 2017
• The fruits & vegetables cold storage market in India was worth US$ XXXX Million in 2012 and it is forecasted to reach US$ XXXX Million by 2017
• The milk and products cold market is expected to account for XXXX% in 2017
India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vege...Renub Research
Renub Research (http://renub.com/report/india-frozen-food-poultry-fishseafood-red-meat-dessert-snacks-and-vegetable-market-volume-forecast-to-2017-92) has announced the addition of the "India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vegetable) Market, Volume & Forecast to 2017" report to its offering
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit